Series D funding round for Enveda Biosciences raising $150M in September 2025
Series D funding round for Enveda Biosciences raising $150M in September 2025
| Investor | Firm Type | Partner |
|---|
Premji InvestLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Henry Kravis | |
| Angel | rajiv chegu | |
| Angel | Chris Gibson |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $150M in a Series D round.
The round was announced on 09/01/25.
The round was led by Akshay Rai.